4//SEC Filing
Adamis Pharmaceuticals Corp 4
Accession 0001387131-14-003147
CIK 0000887247operating
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 4:53 PM ET
Size
5.8 KB
Accession
0001387131-14-003147
Insider Transaction Report
Form 4
ROTHERMEL ROBERT B
Director
Transactions
- Award
Employee Stock Option (right to buy)
2014-08-25+2,942→ 2,942 totalExercise: $4.04Exp: 2024-08-25→ Common Stock (2,942 underlying)
Footnotes (1)
- [F1]The option vests and is exercisable with respect to 1,471 of the shares subject to the option immediately upon the date of grant. The option vests and will become exercisable with respect to the remaining 1,471 shares subject to the option monthly over a period of three (3) years from the date of grant. The option is granted pursuant to the Company's 2009 Equity Incentive Plan and is subject to other provisions as are set forth in the option agreement relating to such grant under the plan.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000887247
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 4:53 PM ET
- Size
- 5.8 KB